Elevated expression of CKS1B at 1q21 is highly correlated with short survival in myeloma.

被引：1
|
作者：
Zhan, FH
Sawyer, J
Gupta, S
Huang, YS
Anaissie, E
Xu, HW
Hanamura, I
Santra, M
Zangari, M
Lee, CK
Fassas, A
van Rhee, F
Hollmig, K
Talamo, G
Thertulian, R
Tricot, G
Barlow, W
Rasmussen, E
Crowley, J
Barlogie, B
John, S
机构：
[1] Univ Arkansas Med Sci, Myeloma Inst Res & Therapy, Little Rock, AR 72205 USA
[2] Canc Res & Biostat, Seattle, WA USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
10.1182/blood.V104.11.77.77
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
77
引用
收藏
页码：26A / 26A
页数：1
相关论文
共 50 条
  • [41] The Survival Impact of 1q+/CKS1B Depends on Background Karyotype and Del(17p)/TP53 Allelic Burden
    Hao, Suyang
    Konoplev, Sergej
    Lu, Xinyan
    Li, Shaoying
    Hu, Shimin
    Xu, Jie
    Tang, Guilin
    Medeiros, L. Jeffrey
    Lin, Pei
    MODERN PATHOLOGY, 2019, 32
  • [42] Deregulation of FCGR2B expression by 1q21 rearrangements in follicular lymphomas
    Weiyi Chen
    Nallasivam Palanisamy
    Helmut Schmidt
    Julie Teruya-Feldstein
    Suresh C Jhanwar
    Andrew D Zelenetz
    Jane Houldsworth
    R S K Chaganti
    Oncogene, 2001, 20 : 7686 - 7693
  • [43] The Survival Impact of 1q+/CKS1B Depends on Background Karyotype and Del(17p)/TP53 Allelic Burden
    Hao, Suyang
    Konoplev, Sergej
    Lu, Xinyan
    Li, Shaoying
    Hu, Shimin
    Xu, Jie
    Tang, Guilin
    Medeiros, L. Jeffrey
    Lin, Pei
    LABORATORY INVESTIGATION, 2019, 99
  • [44] Role of 1q21 in Multiple Myeloma: From Pathogenesis to Possible Therapeutic Targets
    Burroughs Garcia, Jessica
    Eufemiese, Rosa Alba
    Storti, Paola
    Sammarelli, Gabriella
    Craviotto, Luisa
    Todaro, Giannalisa
    Toscani, Denise
    Marchica, Valentina
    Giuliani, Nicola
    CELLS, 2021, 10 (06)
  • [45] Effect of amplification or gain of 1Q21 in patients with multiple myeloma treated with daratumumab
    Zamanillo, Irene
    Medina de Alba, Lucia
    Alonso, Rafael
    Maria Sanchez, Jose
    Cuellar, Clara
    Fernandez-Guijarro, Manuela
    Martinez-Lopez, Joaquin
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S235 - S236
  • [46] THE AMPLIFICATION OF 1Q21 IS AN ADVERSE PROGNOSTIC FACTOR IN CHINESE PATIENTS WITH MULTIPLE MYELOMA
    Chen, L.
    Yu, W.
    Zhang, R.
    Qu, X.
    Qiu, H.
    Guo, R.
    Li, J.
    HAEMATOLOGICA, 2015, 100 : 519 - 519
  • [47] Efficacy of daratumumab in newly diagnosed multiple myeloma patients with 1q21 gain
    Iriuchishima, Hirono
    Saito, Akio
    Mihara, Masahiro
    Terasaki, Yukie
    Matsumoto, Akira
    Isoda, Atsushi
    Furukawa, Yusuke
    Matsumoto, Morio
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 120 (01) : 71 - 79
  • [48] Outcome of Patients with Multiple Myeloma and CKS1B Gene Amplification after Autologous Hematopoietic Stem Cell Transplantation
    Bock, Fabian
    Lu, Gary
    Srour, Samer A.
    Gaballa, Sameh
    Lin, Heather Y.
    Baladandayuthapani, Veerabhadran
    Honhar, Medhavi
    Stich, Maximilian
    Das Shah, Nina
    Bashir, Qaiser
    Patel, Krina
    Popat, Uday
    Hosing, Chitra
    Korbling, Martin
    Delgado, Ruby
    Rondon, Gabriela
    Shah, Jatin J.
    Thomas, Sheeba K.
    Manasanch, Elisabet E.
    Isermann, Berend
    Orlowski, Robert Z.
    Champlin, Richard E.
    Qazilbash, Muzaffar H.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (12) : 2159 - 2164
  • [49] Study on c-myc-Mediated Regulatory Mechanism of CKS1B Transcription in XG1 Multiple Myeloma Cells
    Meng, L. J.
    Xu, J. R.
    Wang, J.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2013, 61 : S309 - S310
  • [50] Molecular cloning and expression analysis of the CKS1B gene from black tiger shrimps (Penaeus monodon)
    Shi, Gongfang
    Zhao, Chao
    Fu, Mingjun
    Qiu, Lihua
    AQUACULTURE RESEARCH, 2017, 48 (09) : 5133 - 5138
12345